Publications by authors named "Lucas Hollanda Oliveira"
The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
Am Heart J
October 2023
Background: It is estimated that atrial fibrillation (AF) affects approximately 1.5 million people in Brazil; however, epidemiological data are limited. We sought to evaluate the characteristics, treatment patterns, and clinical outcomes in patients with AF in Brazil by creating the first nationwide prospective registry.
View Article and Find Full Text PDFEpicardial mapping complicated by multi-vessel coronary spasm and electrical storm.
J Interv Card Electrophysiol
December 2022
The case report describes a severe multi-vessel coronary spasm complicating the epicardial mapping in a patient with chronic Chagas cardiomyopathy.
View Article and Find Full Text PDFArticle Synopsis
- Catheter ablation (CA) is a recommended first-line treatment for symptomatic supraventricular tachycardias (SVT), but patients often experience delays in receiving this procedure.
- A study analyzed 350 patients to identify factors that contribute to non-referral for CA, finding that age, chest discomfort during SVT, and the number of antiarrhythmic drugs used were significant predictors.
- The results suggest biases in medical decision-making that may prevent patients who could benefit from CA from being referred in a timely manner, highlighting a potential underuse of this effective treatment.
Background: Atrial high-rate episodes (AHREs) are associated with an increased risk of cerebral ischemic events; however, there are no studies related to the presence of AHREs and cerebral ischemic events in Chagasic patients.
Objective: To investigate the association between the presence of AHREs ≥ 6 minutes and cerebral ischemic events in Chagasic patients.
Methods: Cohort study with Chagasic patients with implantable electronic cardiac devices (IECDs), followed at the Arrhythmia Outpatient Clinic of a University Hospital, in the city of Salvador, state of Bahia, Brazil, between May 2016 and June 2017.
To discuss and share knowledge about advances in the care of patients with thrombotic disorders, the Ninth International Symposium of Thrombosis and Anticoagulation was held in Salvador, Bahia, Brazil, on October 15, 2016. This scientific program was developed by clinicians for clinicians and was promoted by two major clinical research institutes-the Brazilian Clinical Research Institute and the Duke Clinical Research Institute of the Duke University School of Medicine. Comprising academic presentations and open discussion, the symposium had as its primary goal to educate, motivate, and inspire internists, cardiologists, hematologists, and other physicians by convening national and international visionaries, thought-leaders, and dedicated clinician-scientists.
View Article and Find Full Text PDFBackground And Aims: Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common form of paroxysmal supraventricular tachycardia (SVT) whose diagnosis can be strongly suspected based on the surface eletrocardiogram alone. The purpose of this study is to determine the diagnostic accuracy of several electrocardiographic (ECG) criteria for the prediction of AVNRT.
Methods: Between November 2010 and January 2014, a total of 256 patients who underwent electrophysiological testing (EP) with regular, paroxysmal and narrow QRS complex tachycardia were prospectively enrolled.
Background: Despite the high prevalence and clinical importance of atrial fibrillation (AF), there is no Brazilian study describing the clinical profile of patients with AF and the most used treatment strategy (rhythm control vs. rate control).
Objective: Assess the most common treatment on AF in an outpatient specialized clinic for management of AF.